0.1(top 100%)
impact factor
210(top 50%)
papers
57(top 100%)
citations
3(top 100%)
h-index
0.1(top 100%)
extended IF
211
all documents
60
doc citations
5(top 100%)
g-index

Top Articles

#TitleJournalYearCitations
1Vortioxetine: a review of new antidepressantPsychiatrie Pro Praxi20169
2Results of therapeutically castration by paraphiliac sexual offendersPsychiatrie Pro Praxi20163
3Pregabalin in the treatment of generalized anxiety disorderPsychiatrie Pro Praxi20173
4Pathologic sexual aggression in practicePsychiatrie Pro Praxi20173
5Research of new drugs for Alzheimer's diseasePsychiatrie Pro Praxi20172
6Group CBT therapy for patients with anxiety and depressive disorders experience from practicePsychiatrie Pro Praxi20162
7News in gerontopsychiatryPsychiatrie Pro Praxi20192
8Transformations of addiction treatment - therapy without power (powerlessness)Psychiatrie Pro Praxi20202
9Schizo-obsessive symptomsPsychiatrie Pro Praxi20202
10Multidisciplinary approach and its importance for the mental health of children and adolescents not only in eating disorderPsychiatrie Pro Praxi20211
11Effect of coronavirus epidemic on development and treatment of eating disorders in childhood and adolescencePsychiatrie Pro Praxi20211
12What prevents more successful pharmacological treatment of depressive disorder?Psychiatrie Pro Praxi20191
13Monitoring of adverse events and safety of antidepressantsPsychiatrie Pro Praxi20191
14Therapeutic drug monitoring in psychiatry - possibilities and use in practicePsychiatrie Pro Praxi20161
15Some issues of antidepressant efficacy and tolerability relevant for routine clinical practicePsychiatrie Pro Praxi20161
16Psychosocial risk factors in schizophreniaPsychiatrie Pro Praxi20161
17Aripiprazole in the treatment of bipolar disorder - its use in the clinical practicePsychiatrie Pro Praxi20161
18Indicators of quality of care and their use in psychiatryPsychiatrie Pro Praxi20161
19A new nomenclature for psychotropic agents (Neuroscience-based Nomenclature)Psychiatrie Pro Praxi20161
20Practical risk management in psychiatric care: benefits of root cause analysis and failure modes and effects analysis and their practical usePsychiatrie Pro Praxi20171
21Case report of a patient with Huntington's diseasePsychiatrie Pro Praxi20171
22Bio-psycho-social approach offers more understandingPsychiatrie Pro Praxi20171
23Treatment of depressive disorder with cognitive dysfunctionPsychiatrie Pro Praxi20171
24Rorschach method as a direct Indicator of the particular drug Choice in patients with affective disordersPsychiatrie Pro Praxi20171
25Novel trends in treatment of obsessive-compulsive disorderPsychiatrie Pro Praxi20171
26Consumption of addictive sedatives and hypnotics in the Czech Republic and addiction on these medicinesfrom the consiliary psychiatric viewPsychiatrie Pro Praxi20171
27Pharmacotherapy of Alzheimer disease and neuropsychiatric symptoms of dementiaPsychiatrie Pro Praxi20181
28Pharmacotherapy of Alzheimer disease and neuropsychiatric symptoms of dementiaPsychiatrie Pro Praxi20181
29Psychiatric inpatient suicide in the Czech RepublicPsychiatrie Pro Praxi20181
30Novel treatment possibilities in depression and schizophreniaPsychiatrie Pro Praxi20181
31Off‑label treatment with antidepressants and antipsychoticsPsychiatrie Pro Praxi20191
32Maintenance treatment of schizophrenia with long‑acting injectable antipsychotics - work with patients and their family membersPsychiatrie Pro Praxi20191
33Postpartum mental disorders: specifics and pharmacotherapy. Part One: depression, anxiety disorders, sleep disorders, and ADHDPsychiatrie Pro Praxi20191
34Agomelatin - tolerance with great effectPsychiatrie Pro Praxi20191
35Mental health and immunityPsychiatrie Pro Praxi20201
36Alzheimer's disease, appeal to public healthPsychiatrie Pro Praxi20191
37Trazodone once‑daily in depressionPsychiatrie Pro Praxi20191
38Mobbing in workplace: mechanisms and condsequencesPsychiatrie Pro Praxi20211
39Survey on the topic: Children at risk of pornography and online sexual aggressorsPsychiatrie Pro Praxi20211
40Group CBT for patients with anxiety disorders - reflection of further experience from practicePsychiatrie Pro Praxi20221
41Minority stress in the perspective of health inequalities between heterosexual and non­‑heterosexual peoplePsychiatrie Pro Praxi20221
42Diagnosing major sleep disordersPsychiatrie Pro Praxi20210
43Lurasidon in the treatment of the patient with paranoid schizophrenia previously treated by combination of atypical antipsychotics: case reportPsychiatrie Pro Praxi20210
44Confidentiality obligation of health care professionals and its breaking under the current legislation - Part 3Psychiatrie Pro Praxi20210
45Schizophrenia and intestinal microbiomePsychiatrie Pro Praxi20210
46Factitious disorder: overview and case reportPsychiatrie Pro Praxi20210
47Covid - recommendations how to cope with stressful time. Mental conditions related to SARS-CoV-2Psychiatrie Pro Praxi20210
48The relationship between gut microbiota and behaviorPsychiatrie Pro Praxi20210
49CyclothymiaPsychiatrie Pro Praxi20210
50Effect of fish oil food supplement consumption on omega 3 index and selected cognitive functions in actively sport pupils in the second stage of primary schoolsPsychiatrie Pro Praxi20210